References
Ragozzino MW, Melton III LJ, Kurland LT, et al. Population based study of herpes zoster and its sequelae. Medicine (Baltimore) 1982; 61: 310–6
McGregor RM. Herpes zoster, chicken-pox and cancer in general practice. BMJ 1957; 1: 84–7
Riopelle J, Lopez-Anaya A, Cork RC, et al. Treatment of cutaneous pain of acute herpes zoster with 9% lidocaine (base) in petrolatum/paraffin ointment. J Am Acad Dermatol 1994; 30: 757–67
Litman SJ, Vitkun SA, Poppers PJ. Use of EMLA cream in the treatment of post-herpetic neuralgia. J Clin Anesth 1996; 8: 54–7
Tanelian DL, Brose WG. Neuropathic pain can be relieved by drugs that are use-dependent sodium channel blockers: lidocaine, carbamazepine, and mexiletine. Anesthesiology 1991; 74: 949–51
Baranowski AP, de Courcey J, Bonello E. A trial of intravenous lidocaine on the pain and allodynia of postherpetic neuralgia. J Pain Symptom Manage 1999; 17: 429–33
Rowbotham MC, Davies PS, Verkempinck C, et al. Lidocaine patch: double-blind controlled study of a new treatment method for post-herpetic neuralgia. Pain 1996 Apr; 65: 39–44
Ferrante FM, Paggioli J, Cherukuri S, et al. The analgesic response to intravenous lidocaine in the treatment of neuropathic pain. Anesth Analg 1996; 82: 91–7
Brose WG, Cousins MJ. Subcutaneous lidocaine for treatment of neuropathic cancer pain. Pain 1991; 45; 145–8
Rowbotham MC, Davies PS, Fields HL. Topical lidocaine gel relieves postherpetic neuralgia. Ann Neurol 1995; 37: 246–53
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Baranowski, A.P. Lidocaine Patch 5%. Drugs 59, 250–251 (2000). https://doi.org/10.2165/00003495-200059020-00008
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003495-200059020-00008